Statement of Cash Flows	7 Months Ended
	Dec. 31, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (4,718,021)
Adjustments to reconcile net loss to net cash used in operating activities:
General and administrative expenses paid by related party through note payable	36,280
Compensation cost from issuance of derivative warrant liabilities – private warrants	2,924,805
Gain on marketable securities (net) held in Trust Account	(48)
Change in fair value of derivative warrant liabilities	921,830
Issuance costs – warrant liabilities	645,776
Changes in operating assets and liabilities:
Prepaid expenses	(168,141)
Accounts payable	157,210
Accrued taxes	172,200
Net cash used in operating activities	(28,109)
Cash Flows from Investing Activities
Cash deposited in Trust Account	(58,650,000)
Net cash used in investing activities	(58,650,000)
Cash Flows from Financing Activities:
Repayment of note payable to related party	(157,480)
Proceeds received from initial public offering, gross	57,500,000
Proceeds received from private placement	3,445,000
Offering costs paid	(1,454,040)
Net cash provided by financing activities	59,333,480
Net increase in cash	655,371
Cash - beginning of the period
Cash - end of the period	655,371
Supplemental disclosure of noncash activities:
Offering costs paid by related party in exchange for issuance of Class B common stock	25,000
Offering costs included in accounts payable	21,435
Offering costs included in accrued expenses	70,000
Offering costs paid by related party through note payable	121,200
Deferred underwriting commissions in connection with the initial public offering	2,012,500
Initial value of common stock subject to possible redemption	36,340,978
Change in value of common stock subject to possible redemption	(999,406)
Issuance of Class A common stock to the underwriters	$ 6